A detailed history of Clear Rock Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clear Rock Advisors, LLC holds 20,348 shares of ABBV stock, worth $3.65 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
20,348
Previous 19,921 2.14%
Holding current value
$3.65 Million
Previous $3.63 Billion 3.79%
% of portfolio
1.49%
Previous 1.57%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 03, 2024

BUY
$154.79 - $180.76 $66,095 - $77,184
427 Added 2.14%
20,348 $3.49 Billion
Q1 2024

Jun 07, 2024

BUY
$159.82 - $182.1 $22,534 - $25,676
141 Added 0.71%
19,921 $3.63 Billion
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $2.72 Million - $3.07 Million
19,780 New
19,780 $3.44 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clear Rock Advisors, LLC Portfolio

Follow Clear Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Rock Advisors, LLC with notifications on news.